Kubudirira kweGomarara: Kurapa nemishonga miviri kwakagamuchirwa muChina, zvichiunza tariro itsva kune varwere vane kenza yechiropa yakakura.

Munguva pfupi yapfuura, National Medical Products Administration yeChina yakabvumidza zviri pamutemo mushonga weAnlotinib Hydrochloride nePenpulimab naChia Tai Tianqing wekurapa kwekutanga kwekenza yehepatocellular. Izvi zvinoratidza chiratidzo chechigumi chakabvumidzwa cheAnlotinib Hydrochloride, zvichireva sarudzo itsva yakakosha mumunda wekurapa kenza yechiropa yepamusoro. Kurapa uku kwakavakirwa pachidzidzo chekiriniki chePhase III chakaburitswa mumagazini inozivikanwa pasi rose ye *The Lancet Oncology*, ine data rayo rinoshamisa rekushanda rinounza tariro itsva kuvarwere pasi rese.

**Kubudirira muKutsvagurudza: Kunowedzera Nguva Yekurarama Uye Kunoderedza Njodzi Yezvirwere**
Chidzidzo ichi, chinonzi ALTN-AK105-III-02, ikiriniki yePhase III ine nzvimbo dzakawanda, yakarongeka, yakavhurika, inodzorwa neparallel yakagadzirirwa kuongorora mashandiro eAnlotinib Hydrochloride pamwe chete nePenpulimab zvichienzaniswa nemushonga wekare weSorafenib mukurapa kwechirwere chehepatocellular carcinoma. Chidzidzo ichi chakanyoresa varwere vanosvika 649 vane chirwere chegomarara rechiropa, avo vanosvika 41% vaive nechirwere chemwoyo, uye vanosvika 49.2% vaive nemazinga e alpha-fetoprotein akakwira (≥400 ng/mL). Hunhu uhwu hunowanzo ratidza matambudziko makuru ekurapa.

Mhedzisiro yekudzidza iyi inokurudzira:
- **Kurebeswa Kwakakosha Kwekurarama Pasina Kufambira Mberi:** Nguva yepakati yekupona isina kuenderera mberi muboka remishonga inosanganiswa yakasvika mwedzi 6.9, ichipfuura zvikuru mwedzi 2.8 muboka revarwere, nekudzikira kwe47% kwenjodzi yekufambira mberi kwechirwere kana kufa.
- **Kuvandudzika Kunoonekwa Mukurarama Kwese:** Avhareji yekurarama kwese muboka remishonga yakabatana yaive mwedzi 16.5, zvichienzaniswa nemwedzi 13.2 muboka revarwere, zvichireva kudzikira kwe31% munjodzi yekufa.

Ruzivo urwu rwe "dual positive endpoint" harungoratidzi chete zvakanakira kurapwa uku mukunonotsa kufambira mberi kwechirwere asiwo runoratidza kubudirira kukuru mukubudirira kwehupenyu hwese, zvichipa nzira dzekurapa dzinoshanda zvakanyanya kune varwere vane kenza yechiropa yakakwira.

**Dhipatimendi reBeijing South Region Oncology Hospital International: Mubatsiri Wako wePasirose wekurwisa Cancer**
Kana tichitarisana negomarara, kuwana ruzivo rwezvekurapa rwakavimbika uye rutsigiro rwekurapa rwenyanzvi kwakakosha. Dhipatimendi reBeijing South Region Oncology Hospital International rakatsaurira kupa mabasa akazara ekuongorora kenza uye ekurapa varwere vekune dzimwe nyika, kusanganisira kubvunzana nezvekurapa kwazvino, kuronga kurapwa kwakagadzirirwa munhu wega, uye rubatsiro rwekutaurirana nemitauro yakasiyana. Tinoshanda pamwe chete nemasangano ekutsvagisa emuno neekunze kwenyika kuona kuti varwere vanobatsirwa nekufambira mberi kwehunyanzvi senge Anlotinib Hydrochloride combination therapy.

**Ruzivo rwekuonana: Tiripo kuti tikushumirei**
Kana iwe kana vadikanwi vako muchitsvaga nzira dzekurapa kenza yechiropa yakakwira kana mamwe mabundu, ndapota taura nesu nekukasika uchishandisa nzira dzinotevera. Chikwata chedu chehunyanzvi chichapa sumo dzakadzama dzekurapa, gwara rekurapa, uye rutsigiro kuvarwere vekune dzimwe nyika:
- **Nhare:** 400-880-3716
Fonera nhamba iyi kuti utaure zvakananga nevarongi vedu vevarwere vepasi rose kuti uwane mazano nekukurumidza uye rubatsiro rwekugadzwa.
- **WeChat:** 17801183037
Wedzera account yedu yepamutemo yeWeChat kuti uwane ruzivo rwekurapwa panguva chaiyo, mibvunzo yepamhepo, kana kubvunzana nevhidhiyo.
- **Email:**
① 100085_010@163.com
② myimmnet@163.com
Tumira zvinyorwa zvekurapa kana mibvunzo kuemail yedu, uye timu yedu yenyanzvi ichapa mazano ekurapa akagadzirirwa iwe pachako.

**Sei Uchifanira Kusarudza Isu?**
- **Kuwanikwa Kwemishonga Yepamusoro-soro:** Tinoramba tichitevera mafambiro epasi rose ekurapa oncology kuitira kuti varwere vawane mikana yekuwana mhinduro itsva senge Anlotinib Hydrochloride combination therapy.
- **Mabasa Emitauro Yakawanda:** Tinopa rutsigiro mumitauro yakawanda, kusanganisira Chirungu, kubvisa zvipingamupinyi zvekutaurirana uye kuona kuti varwere vekune dzimwe nyika vanowana ruzivo rwakakwana.
- **Rubatsiro Rwakakwana:** Kubva pakukumbira mavhiza uye kuronga pekugara kusvika pakutevera kurapwa, tinopa masevhisi ekunyatsoteerera.

Kurapwa kwegomarara kunoda nguva yakawanda. Kubvumidzwa kweAnlotinib Hydrochloride combination therapy kwaunza tariro itsva kuvarwere vane gomarara rechiropa rakawedzera. Pasinei nekuti uri kupi, Beijing South Region Oncology Hospital International Department yakagadzirira kuva mubatsiri wako akasimba parwendo rwako rwekurwisa gomarara. Taura nesu nhasi kuti utange rwendo rwako rwekurapwa rwakagadzirirwa iwe pachako!

**Rangarira Ruzivo Rwedu Rwekutaurirana:**
Nhare: 400-880-3716
WeChat: 17801183037
Email: 100085_010@163.com or myimmnet@163.com
Tinotarisira kukupai rubatsiro rwezvekurapa rwehunyanzvi uye rwetsitsi!

微信图片_20241115181717


Nguva yekutumira: Ndira-27-2026